Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Study of the effect of 1-({4-[(2,4-dichlorobenzoyl)amino]phenyl}sulfonyl-(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (GGM-27) on tumor growth and survival in BALB/c mice bearing ACATOL colon adenocarcinoma in comparison with doxorubicin

Дата публикации: 29-06-2026 21:00:00

Introduction. Matrix metalloproteinases (MMPs) belong to the family of zinc-dependent endopeptidases capable of degrading the main components of extracellular matrix proteins that form the basis of connective tissue; they are also involved in many pathological processes in the body. MMP-2 is actively expressed in lung cancer tissues, while MMP-2 and MMP-9 play a significant role in the development of colorectal cancer.Objective. To evaluate the effect of 1-({4-[(2,4-dichlorobenzoyl)amino]phenyl}sulfonyl-(2S,4R)-4-hydroxypyrrolidine-2 carboxylic acid (GGM-27) on tumor growth and survival in BALB/c mice using the AKATOL colon adenocarcinoma model.Materials and methods. AKATOL colon adenocarcinoma was implanted subcutaneously into the axillary region of male BALB/c mice at a dose of 1×10⁶ cells. From day 2 to day 15 of tumor development, GGM-27 was administered intraperitoneally (i.p.) at doses of 1 mg/kg and 10 mg/kg. Doxorubicin was used as a reference drug, administered at a dose of 5 mg/kg i.p. on days 2 and 4 of tumor development. The antitumor activity of GGM-27 was assessed by tumor growth inhibition (TGI) and lifespan extension (LSE).Results. After a 14-day course of i.p. administration of GGM-27 at a dose of 1 mg/kg, TGI was 72.8 % on day 21 of the experiment and 71 % on day 28. After i.p. administration of GGM-27 at a dose of 10 mg/kg, TGI was 63 % on day 21 and 56% on day 28. LSE after a course of GGM-27 at a dose of 10 mg/kg was 24 %. After two i.p. administrations of doxorubicin at a dose of 5 mg/kg, TGI was 82 % on day 21 and 69 % on day 28; however, two of the 12 animals died due to drug toxicity.Conclusions. Administration of 1-({4-[(2,4-dichlorobenzoyl)amino]phenyl}sulfonyl-(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid at a dose of 1 mg/kg caused TGI. On day 21 of the experiment, with GGM-27 administration, TGI was 73 %, and on day 28, TGI was 71 %.

Основное содержимое страницы с новостью.


nginx

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Nephroprotective activity of resveratrol in cisplatin-induced acute kidney injury07.8129-06-2026
2Assessment of mutagenicity and acute toxicity of linear substituted glyproline – ethyl ester of N-phenylacetylglycyl-L-proline07.2329-06-2026
3Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer07.4823-09-2026
4Protein modification network plays vital role in cancer development06.8124-09-2026
5Comparative study of antiarrhythmic and anti-ischemic activity of various salts of n1-(2,3,4-trimethoxybenzyl)-n2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethane-diamine06.0729-06-2026
6G7 renews global drive to accelerate fight against cancer04.1918-06-2026
7MPP au Congrès mondial contre le cancer 202609.6604-09-2026
8Development of a self-emulsifying delivery system N-(adamant-2-yl)-N-(para-bromophenyl)amine (adamantylbromophenylamine) in the form of a medicinal drug for oral administration. Part 107.7229-06-2026
9A new treatment has been approved for extensive-stage small cell lung cancer07.6624-09-2026
10Designing and synthesis of a new dimeric dipeptide mimetic of the 4th loop of neurotrophin-3 <i>bis-(N</i>-monoglutaryl-L-asparaginyl-Lasparagine) hexamethidenediamide and its D,D-stereoisomer05.8329-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.45. Источник: www.pharmacokinetica.ru.